The potential for probiotics to prevent bacterial vaginosis and preterm labor+

American Journal of Obstetrics and Gynecology

Volumn 189, Issue 4, 2003, Pages 1202-1208

  Reid, Gregor ^a,b   Bocking, Alan ^a  

^a UNIVERSITY OF WESTERN ONTARIO   (Canada)

^b LAWSON HEALTH RESEARCH INSTITUTE   (Canada)

Author keywords

Bacterial vaginosis; Preterm labor; Probiotics; Vaginal microflora

Indexed keywords

ANTIBIOTIC AGENT; CYTOKINE; PROBIOTIC AGENT;

ANTIBIOTIC THERAPY; CANADA; EMBRYO DEVELOPMENT; HEALTH CARE SYSTEM; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; PREMATURE LABOR; PRIORITY JOURNAL; QUALITY OF LIFE; REVIEW; SEXUALLY TRANSMITTED DISEASE; UROGENITAL TRACT INFECTION; VAGINA FLORA; VAGINITIS;

EID: 0242509100     PISSN: 00029378     EISSN: None     Source Type: Journal    
DOI: 10.1067/S0002-9378(03)00495-2     Document Type: Article

References (104)

1. Canadian Perinatal Surveillance System, Reproductive Health Division, Bureau of Reproductive and Child Health, Preterm Birth. 1999.
2. Joseph KS, Kramer MS, Marcoux S, Ohlsson A, Wu Wen S, Allen A, et al. Determinants of preterm birth rates in Canada from 1981 through 1983 and from 1992 through 1994. N Engl J Med 1998; 339:1434-9.
3. European community collaborative study of outcome of pregnancy between 22 and 28 weeks' gestation: working group on the very low birthweight infant. Lancet 1990;336:782-4.
4. Chan K, Ohlsson A, Synnes A, Lee DSC, Chien L, Lee SK, et al. Survival, morbidity, and resource use of infants of 25 weeks gestational age or less. Am J Obstet Gynecol 2001;185:220-6.
5. Hack M, Flannery DJ, Schluchter M, Cartar L, Borawski E, Klein N. Outcomes in young adulthood for very-low-birth-weight infants. N Engl J Med 2002;346:149-57.
6. McCormick CM. The contribution of low birth weight to infant mortality and childhood morbidity. N Engl J Med 1985;312:82-90.
7. Nicholson WK, Frick KD, Powe NR. Economic burden of hospitalizations for preterm labor in the United States. Obstet Gynecol 2000;96:95-101.
8. Romero R, Avila C, Brekus CA, Morotti R. The role of systemic and intrauterine infection in preterm parturition. Ann N Y Acad Sci 1991;662:355-75.
9. MacDonald PC, Caey ML. Preterm birth. Sci Am Sci Med 1996;3: 42-51.
10. Mitchell MD, Branch DW, Lundin-Schiller S, Romero RJ, Daynes RA, Dudley DJ. Immunologic aspects of preterm labour. Semin Perinatol 1991:15:210-24.
11. Martinez JJ, Hultgren SJ. Requirement of Rho-family GTPases in the invasion of type 1-piliated uropathogenic Escherichia coli. Cell Microbiol 2002;4:19-28.
12. Carbone M, Hasty DL, Yi KC, Rue J, Fera MT, La Torre F, et al. Cytokine induction in murine bladder tissue by type 1 fimbriated Escherichia coli. Ann N Y Acad Sci 2002;963:332-5.
13. Romero R, Baumann P, Gomez R, Salafia C, Rittenhouse L, Barberio D, et al. The relationship between spontaneous rupture of membranes, labor, and microbial invasion of the amniotic cavity and amniotic fluid concentrations of prostaglandins and thromboxane B2 in term pregnancy. Am J Obstet Gynecol 1993;168: 1654-64.
14. Splichal I, Trebichavsky I. Cytokines and other important inflammatory mediators in gestation and bacterial intraamniotic infections. Folia Microbiol (Praha) 2001;46:345-51.
15. Smayevsky J, Canigia LF, Lanza A, Bianchini H. Vaginal microflora associated with bacterial vaginosis in nonpregnant women: reliability of sialidase detection. Infect Dis Obstet Gynecol 2001;9:17-22.
16. Cauci S, Guaschino S, Driussi S, De Santo D, Lanzafame P, Quadrifoglio F. Correlation of local interleukin-8 with immunoglobulin A against Gardnerella vaginalis hemolysin and with prolidase and sialidase levels in women with bacterial vaginosis. J Infect Dis 2002;185:1614-20.
17. 2-generating lactobacilli. J Infect Dis 1991;164:94-10.
18. Sato TA, Keelan JA, Mitchell MD. Regulation of prostaglandin production in an immortalized human myometrial cell line by cytokines and non-steroidal anti-inflammatory drugs. Eur J Obstet Gynecol Reprod Biol 2002;100:158-62.
19. Amsel R, Totten PA, Speigel CA, Chen KSC, Eschenbach D, Holmes KK. Nonspecific vaginitis: diagnostic criteria and microbial and epidemiologic associations. Am J Med 1983;74:14-22.
20. Hillier SL. Diagnostic microbiology of bacterial vaginosis. Am J Obstet Gynecol 1993;169:455-9.
21. Nugent RP, Krohn MA, Hillier SL. Reliability of diagnosing bacterial vaginosis is improved by a standardized method of Gram stain interpretation. J Clin Microbiol 1991;29:297-301.
22. Pastore LM, Thorp JM Jr, Royce RA, Savitz DA, Jackson TP. Risk score for antenatal bacterial vaginosis: BV PIN points. J Perinatol 2002;22:125-32.
23. Culhane JF, Rauh V, McCollum KF, Hogan VK, Agnew K, Wadhwa PD. Maternal stress is associated with bacterial vaginosis in human pregnancy. Matern Child Health J 2001;5:127-34.
24. Sihvo S, Ahonen R, Mikander H, Hemminki E. Self-medication with vaginal antifungal drugs: physicians' experiences and women's utilization patterns. Fam Pract 2000;17:145-9.
25. Hay PE, Taylor-Robinson D. Defining bacterial vaginosis: to BV or not to BV that is the question. Int J Sex Trans Dis AIDS 1996;7:233-5.
26. Carroll SG, Papioannou S, Ntumazah IL, Philpott-Howard J, Nicolaides KH. Lower genital tract swabs in the prediction of intrauterine infection in preterm prelabour rupture of the membranes. BJOG 1996;103:54-9.
27. Mardh P-A, Taylor-Robinson D. Bacterial vaginosis. Stockholm: Almqvist and Wiksell International; 1984.
28. Van der Meijden WI. Clinical aspects of Gardnerella vaginalis - associated vaginitis: a review of the literature. In: Mardh P-A, Taylor-Robinson D, editors. Bacterial vaginosis. Stockholm: Almqvist & Wiksell International; 1984.
29. Westrom L, Evaldson G, Holmes KK, et al. Taxonomy of vaginosis; bacterial vaginosis - a definition. In: Mardh P-A, Taylor-Robinson D, editors. Bacterial vaginosis. Stockholm: Almqvist & Wiksell International; 1984. p. 259-60.
30. Speigel CA, Amsel R, Eschenbach D, Schoenknecht F, Holmes KK. Anaerobic bacteria in nonspecific vaginitis. N Engl J Med 1980; 303:601-7.
31. Cook RL, Reid G, Pond DG, Schmitt CA, Sobel JD. Clue cells in bacterial vaginosis: immunofluorescent identification of the adherent gram-negative bacteria as Gardnerella vaginalis. J Infect Dis 1989; 160:490-6.
32. 2-producing lactobacilli, and bacterial vaginosis in pregnant women. Clin Infect Dis 1993;16:S273-81.
33. Holst E, Goffeng AR, Andersch B. Bacterial vaginosis and vaginal microorganisms in idiopathic premature labour and association with pregnancy outcome. J Clin Microbiol 1994;32:176-86.
34. Scwebke JR, Richey CM, Weiss HL. Correlation of behaviors with microbiological changes in vaginal flora. J Infect Dis 1999;180:1632-6.
35. Keane FE, Ison CA, Taylor-Robinson D. A longitudinal study of the vaginal flora over a menstrual cycle. Int J STD AIDS 1997;8:489-94.
36. Goldenberg RL, Klebanoff MA, Nugent R, Krohn MA, Hillier SL, Andrews WW. Bacterial colonization of the vagina during pregnancy in four ethnic groups: vaginal infections and prematurity. Am J Obstet Gynecol 1996;174:1618-21.
37. Goldenberg RL, Andrews WW, Yuan AC, MacKay HT, St Louis ME. Sexually transmitted diseases and adverse outcomes of pregnancy. Clin Perinatol 1997;24:23-41.
38. Chaim W, Mazor M, Leiberman JR. The relationship between bacterial vaginosis and preterm birth. Arch Gynecol Obstet 1997; 259:51-8.
39. Wawer MJ, Serwadda D, Musgrave SD, Konde-Lule JK, Musagara M, Sewankambo NK. Dynamics of spread of HIV-1 infection in a rural district of Uganda. BMJ 1991;303:1303-6.
40. Cohen CR, Duerr A, Pruithithada N, Rugpao S, Hillier S, Garcia P, et al. Bacterial vaginosis and HIV seroprevalence among female commercial sex workers in Chiang Mai, Thailand. AIDS 1995; 9:1093-7.
41. Dalabetta GA, Miotti PG, Chiphangwi JD, Liomba G, Canner JK, Saah AJ. Traditional vaginal agents: use and association with HIV infection in Malawian women. AIDS 1995;9:293-7.
42. Gresenguet G, Kreiss JK, Chapko MK. Hillier SL, Weiss NS. HIV infection and vaginal douching in Central Africa. AIDS 1997;11: 101-6.
43. Martin HL, Nyange PM, Richardson, BA, et al. Association between presence of vaginal lactobacilli and acquisition of HIV and STDs [abstract]. Proceedings of the eleventh International Conference on AIDS; 1996 July; Vancouver, British Columbia, Canada. Vancouver: The Conference; 1996 p. 7-12.
44. McFarland LV, Elmer GW. Pharmaceutical probiotics for the treatment of anaerobic and other infections. Anaerobe 1997;3: 73-8.
45. Sewankambo N, Gray RH, Wawer MJ, Paxton L, McNaim D, Wabwire-Mangen F, et al. HIV-1 infection associated with abnormal vaginal flora morphology and bacterial vaginosis. Lancet 1997; 350:530-1.
46. Hillier SL, Nugent RP, Eschenbach DA, Krohn MA, Gibbs RS, Martin DH, et al. Association between bacterial vaginosis and preterm delivery of a low-birth-weight infant. N Engl J Med 1995;333:1737-42.
47. Hauth JC, Goldenberg RL, Andrews WW, DuBard MB, Copper RL. Reduced incidence of preterm delivery with metronidazole and erythromycin in women with bacterial vaginosis. N Engl J Med 1995;333:1732-6.
48. Kekki M, Kurki T, Pelkonen J, Kurkinen-Raty M, Cacciatore B, Paavonen J. Vaginal clindamycin in preventing preterm birth and peripartal infections in asymptomatic women with bacterial vaginosis: a randomized, controlled trial. Obstet Gynecol 2001;97:643-8.
49. Mittendorf R, Williams MA, Kass EH. Prevention of preterm delivery and low birth weight associated with asymptomatic bacteriuria. Clin Infect Dis 1992;14:927-32.
50. Terrone DA, Rinehart BK, Einstein MH, Britt LB, Martin JN Jr, Perry KG. Neonatal sepsis and death caused by resistant Escherichia coli: possible consequences of extended maternal ampicillin administration. Am J Obstet Gynecol 1999;180:1345-8.
51. Reid G, Habash M. Urogenital microflora and urinary tract infections. In: Tannock GW, editor. Medical importance of the normal microflora. London: Kluwer; 1998. p. 423-40.
52. Sobel JD. Biotherapeutic agents as therapy for vaginitis. In: Elmer G, et al, editors. Biotherapeutic agents and infectious diseases. Totowa (NJ): Humana Press; 1999. p. 316.
53. Giorgi A, Torriani S, Dellaglio F, Bo G, Stola E, Bernuzzi L, et al. Identification of vaginal lactobacilli from asymptomatic women. Microbiologica 1987;10:377-84.
54. Reid G, McGroarty JA, Tomeczek L, Bruce AW. Identification and plasmid profiles of Lactobacillus species from the vagina of 100 healthy women. FEMS Immunol. Med. Microbiol 1996;15:23-6.
55. Burton JP, Cadieux P, Reid G. Improved understanding of the bacterial vaginal microbiota of women before and after probiotic instillation. Appl Environ Microbiol 2003;69:97-101.
56. Hillier SL, Krohn MA, Klebanoff SJ, Eschenbach DA. The relationship of hydrogen peroxide-producing lactobacilli to bacterial vaginosis and genital microflora in pregnant women. Obstet Gynecol 1992;79:369-73.
57. FAO/WHO. Joint FAO/WHO expert consultation on evaluation of health and nutritional properties of probiotics in food; 2001 October 1-4; Córdoba, Argentina. Available from: http:// www.fao.org/es/esn/Probio/report.pdf. Accessed December 2001.
58. Jones PJ. Clinical nutrition, 7: functional foods - more than just nutrition. CMAJ 2002;166L:1555-63.
59. FAO/WHO. Joint FAO/WHO Working Group report on food guidelines for the evaluation of probiotics in food; 2002 April 30-May 1; London Ontario, Canada. Available from: http:// www.fao.org/es/esn/Probio/wgreport2.pdf. Accessed May 2002.
60. Reid G, Zalai C, Gardiner G. Urogenital lactobacilli probiotics, reliability and regulatory issues. J Dairy Sci 2001;84(E Suppl): E164-9.
61. Hughes VL, Hillier SL. Microbiologic characteristics of Lactobacillus products used for colonization of the vagina. Obstet Gynecol 1990; 75:244-8.
62. Hamilton-Miller JM, Shah S, Winkler JT. Public health issues arising from microbiological and labelling quality of foods and supplements containing probiotic microorganisms. Public Health Nutr 1999;2:223-9.
63. Zhong W, Millsap K, Bialkowska-Hobrzanska H, Reid G. Differentiation of Lactobacillus species by molecular typing. Appl Environ Microbiol 1998;64:2418-23.
64. Kalliomaki M, Salminen S, Arvilommi H, Kero P, Koskinen P, Isolauri E. Probiotics in primary prevention of atopic disease: a randomised placebo-controlled trial. Lancet 2001;357:1076-9.
65. Reid G, Bruce AW. Selection of Lactobacillus strains for urogenital probiotic applications. J Infect Dis 2001;183(1 Suppl):S77-80.
66. Reid G, Cook RL, Bruce AW. Examination of strains of lactobacilli for properties which may influence bacterial interference in the urinary tract. J Urol 1987;138:330-5.
67. Reid G, Charbonneau D, Gonzalez S, Gardiner G, Erb J, Bruce AW. Ability of Laclobacillus GR-1 and RC-14 to stimulate host defences and reduce gut translocation and infectivity of Salmonella typhimurium. Nutraceut. Food 2002;7:168-73.
68. Reid G, Bruce AW, Taylor M. Instillation of Lactobacillus and stimulation of indigenous organisms to prevent recurrence of urinary tract infections. Microecol Ther 1995;23:32-45.
69. Reid G, Bruce AW, Fraser N, Heinemann C, Owen J, Henning B. Oral probiotics can resolve urogenital infections. FEMS Immunol Med Microbiol 2001;30:49-52.
70. Reid G, Beuerman D, Heinemann C, Bruce AW. Probiotic Lactobacillus dose required to restore and maintain a normal vaginal flora. FEMS Immunol Med Microbiol 2001;32:37-41.
71. Gardiner G, Heinemann C, Baroja ML, Bruce AW, Beuerman D, Madrenas J, et al. Oral administration of the probiotic combination Lactobacillus rhamnosus GR-1 and L fermentum RC-14 for human intestinal applications. Int Dairy J 2002;12:191-6.
72. Cadieux P, Burton J, Kang CY, Gardiner G, Braunstein I, Bruce AW, et al. Lactobacillus strains vaginal ecology. JAMA 2002;287:1940-1.
73. Reid G, Charbonneau D, Erb J, Kochanowski B, Beuerman D, Poehner R et al. Oral use of Lactobacillus rhamnosus GR-1 and L fermentum RC-14 significantly alters vaginal flora: randomized, placebo-controlled trial in 64 healthy women. FEMS Immunol. Med Microbiol 2003;35:131-4.
74. Chlebecek J, Reich I. Fermalac vaginal (Rougier Inc) in the prevention of colpitis in pregnancy [in Czech]. Cesk Gynekol 1993; 58:237-8.
75. Ocana V, Nader-Macias ME. Adhesion of Lactobacillus vaginal strains with probiotic properties to vaginal epithelial cells. Biocell 2001; 25:265-73.
76. Famularo G, Pieluigi M, Coccia R, Mastroiacovo P, De Simone C. Microecology, bacterial vaginosis and probiotics: perspectives for bacteriotherapy. Med Hypotheses 2001;56:421-30.
77. Kekki M, Kurki T, Paavonen J, Rutanen EM. Insulin-like growth factor binding protein-1 in cervix as a marker of infectious complications in pregnant women with bacterial vaginosis. Lancet 1999;353:1494.
78. Wilson T, Ganendren R. Serum concentrations of secretory IgA in pregnancies delivering at term or preterm. Prostaglandins 1992;44:373-8.
79. Schilling JD, Mulvey MA, Vincent CD, Lorenz RG, Hultgren SJ. Bacterial invasion augments epithelial cytokine responses to Escherichia coli through a lipopolysaccharide-dependent mechanism. J Immunol 2001;166:1148-55.
80. Kim JS, Kim JM, Jung HC, Song IS. Expression of cyclooxygenase-2 in human neutrophils activated by Helicobacter pylori water-soluble proteins: possible involvement of NF-kappaB and MAP kinase signaling pathway. Dig Dis Sci 2001;46(10):2277-84.
81. Lopez-Urrutia L, Alonso A, Bayon Y, Nieto ML, Orduna A, Sanchez Crespo M. Brucella lipopolysaccharides induce cyclooxygenase-2 expression in monocytic cells. Biochem Biophys Res Commun 2001;289:372-5.
82. Wenstrom KD, Andrews WW, Hauth JC, Goldenberg RL, DuBard MB, Cliver SP. Elevated second-trimester amniotic fluid interleukin-6 levels predict preterm delivery. Am J Obstet Gynecol 1998;178: 546-50.
83. Steinborn A, Niederhut A, Solbach C, Hildenbrand R, Sohn C, Kaufmann M. Cytokine release from placental endothelial cells, a process associated with preterm labour in the absence of intrauterine infection. Cytokine 1999;11:66-73.
84. Mussalli GM, Blanchard R, Brunnert SR, Hirsch E. Inflammatory cytokines in a murine model of infection-induced preterm labor: cause or effect? J Soc Gynecol Investig 1999;6:188-95.
85. Pacora P, Romero R, Maymon E, Gervasi MT, Gomez R, Edwin SS, et al. Participation of the novel cytokine interleukin 18 in the host response to intra-amniotic infection. Am J Obstet Gynecol 2000; 183:1138-43.
86. Harirah H, Donia SE, Hsu CD. Amniotic fluid matrix metalloproteinase-9 and interleukin-6 in predicting intra-amniotic infection. Obstet Gynecol 2002;99:80-4.
87. Polgar K, Hill JA. Identification of the white blood cell populations responsible for Th1 immunity to trophoblast and the timing of the response in women with recurrent pregnancy loss. Gynecol Obstet Invest 2002;53:59-64.
88. Zourbas S, Dubanchet S, Martal J, Chaouat G. Localization of proinflammatory (IL-12, IL-15) and anti-inflammatory (IL-11, IL-13) cytokines at the foetomaternal interface during murine pregnancy. Clin Exp Immunol 2001;126:519-28.
89. Kurkinen-Raty M, Ruokonen A, Vuopala S, Koskela M, Rutanen EM, Karkkainen T, et al. Combination of cervical interleukin-6 and -8, phosphorylated insulin-like growth factor-binding protein-1 and transvaginal cervical ultrasonography in assessment of the risk of preterm birth. BJOG 2001;108:875-81.
90. Howard J, Heinemann C, Thatcher BJ, Martin B, Gan BS, Reid G. Identification of collagen-binding proteins in Lactobacillus spp with surface-enhanced laser desorption/ionization-time of flight ProteinChip technology. Appl Environ Microbiol 2000;66:4396-400.
91. von der Weid T, Bulliard C, Schiffrin EJ. Induction by a lactic acid bacterium of a population of CD4(+) T cells with low proliferative capacity that produce transforming growth factor beta and interleukin-10. Clin Diagn Lab Immunol 2001;8:695-701.
92. Fortunato SJ, Menon R, Lombardi SJ. Interleukin-10 and transforming growth factor-beta inhibit amniochorion tumor necrosis factor-alpha production by contrasting mechanisms of action: therapeutic implications in prematurity. Am J Obstet Gynecol 1997; 177:803-9.
93. Ulisse S, Gionchetti P, D'Alo S, Russo FP, Pesce I, Ricci G, et al. Expression of cytokines, inducible nitric oxide synthase, and matrix metalloproteinases in pouchitis: effects of probiotic treatment. Am J Gastroenterol 2001;96:2691-9.
94. Piccinni MP, Scaletti C, Mavilia C, Lazzeri E, Romagnani P, Natali I, et al. Production of IL-4 and leukemia inhibitory factor by T cells of the cumulus oophorus: a favorable microenvironment for preimplantation embryo development. Eur J Immunol 2001;31:2431-7.
95. Harris MA, Hansen RA, Vidsudhiphan P, Koslo JL, Thomas JB, Watkins BA, et al. Effects of conjugated linoleic acids and docosahexaenoic acid on rat liver and reproductive tissue fatty acids, prostaglandins and matrix metalloproteinase production. Prostaglandins Leukot Essent Fatty Acids 2001;65:23-9.
96. Perdigon G, Fuller R, Raya R. Lactic acid bacteria and their effect on the immune system. Curr Issues Intest Microbiol 2001;2:27-42.
97. Jiang J, Bjorck L, Fonden R. Production of conjugated linoleic acid by dairy starter cultures. J Appl Microbiol 1998;85:95-102.
98. Elias SL, Innis SM. Infant plasma trans, n-6, and n-3 fatty acids and conjugated linoleic acids are related to maternal plasma fatty acids, length of gestation, and birth weight and length. Am J Clin Nutr 2001;73:807-14.
99. Bengmark S. Progress in perioperative enteral tube feeding. Clin Nutr 1998;17:145-52.
100. Komatsu S, Berg RD, Russell JM, Nimura Y, Granger DN. Enteric microflora contribute to constitutive ICAM-1 expression on vascular endothelial cells. Am J Physiol Gastrointest Liver Physiol 2000; 279:G186-91.
101. Jacobsson B, Pernevi P, Chidekel L, Jorgen Platz-Christensen J. Bacterial vaginosis in early pregnancy may predispose for preterm birth and postpartum endometritis. Acta Obstet Gynecol Scand 2002;81:1006-10.
102. Cauci S, Hitti J, Noonan C, Agnew K, Quadrifoglio F, Hillier SL, et al. Vaginal hydrolytic enzymes, immunoglobulin A against Gardnerella vaginalis toxin, and risk of early preterm birth among women in preterm labor with bacterial vaginosis or intermediate flora. Am J Obstet Gynecol 2002;187:877-81.
103. Cauci S, Guaschino S, De Aloysio D, Driussi S, De Santo D, Penacchioni P, et al. Interrelationships of interleukin-8 with interleukin-1beta and neutrophils in vaginal fluid of healthy and bacterial vaginosis positive women. Mol Hum Reprod 2003;9:53-8.
104. Cauci S, Thorsen P, Schendel DE, Bremmelgaard A, Quadrifoglio F, Guaschino S. Determination of immunoglobulin A against Gardnerella vaginalis hemolysin, sialidase, and prolidase activities in vaginal fluid: implications for adverse pregnancy outcomes. J Clin Microbiol 2003;41:435-8.